Free Trial

Promising Mid Cap Stocks To Follow Today - November 16th

IREN logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • IREN, American Airlines Group, and CG Oncology were highlighted as mid-cap stocks with especially high recent dollar trading volume.
  • IREN fell $1.64 to $16.53 on about 58.4 million shares traded—above its average volume—and was close to its 52-week low of $16.01.
  • CG Oncology jumped $11.45 to $85.84 on roughly 6.8 million shares, around six times its average volume; American Airlines edged up $0.03 to $13.20.
  • MarketBeat previews the top five stocks to own by December 1st.

IREN, American Airlines Group, and CG Oncology are the three Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid-cap stocks are shares of companies with a medium-sized market capitalization, typically between about $2 billion and $10 billion, though the exact range varies by index or provider. Investors often view them as offering more growth potential than large-cap stocks, while generally carrying less risk than small-cap stocks. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.

IREN (IREN)

IREN Limited, formerly known as Iris Energy Limited, owns and operates bitcoin mining data centers. The company was incorporated in 2018 and is headquartered in Sydney, Australia.

IREN traded down $1.64 during mid-day trading on Monday, reaching $16.53. 58,356,542 shares of the stock were exchanged, compared to its average volume of 45,392,840. The company has a debt-to-equity ratio of 1.77, a quick ratio of 1.60 and a current ratio of 1.60. The stock has a market capitalization of $7.01 billion, a PE ratio of -4.06 and a beta of 4.33. The company has a 50 day moving average price of $34.05 and a two-hundred day moving average price of $42.73. IREN has a 1 year low of $16.01 and a 1 year high of $70.71.

Read Our Latest Research Report on IREN

American Airlines Group (AAL)

American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo.

Shares of AAL traded up $0.03 during trading hours on Monday, reaching $13.20. 44,414,972 shares of the stock traded hands, compared to its average volume of 76,248,867. The stock has a fifty day simple moving average of $12.94 and a 200 day simple moving average of $13.49. American Airlines Group has a 52 week low of $10.09 and a 52 week high of $18.79. The company has a market cap of $8.75 billion, a price-to-earnings ratio of -18.05 and a beta of 1.45.

Read Our Latest Research Report on AAL

CG Oncology (CGON)

CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients.

CGON stock traded up $11.45 during trading on Monday, reaching $85.84. The stock had a trading volume of 6,797,376 shares, compared to its average volume of 1,129,252. The company has a market capitalization of $7.67 billion, a price-to-earnings ratio of -31.30 and a beta of 0.35. CG Oncology has a one year low of $37.01 and a one year high of $93.95. The company's 50 day moving average is $68.04 and its two-hundred day moving average is $66.54.

Read Our Latest Research Report on CGON

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in IREN Right Now?

Before you consider IREN, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IREN wasn't on the list.

While IREN currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines